Have your own idea? Try our Stock Screener
Egyptian (CASE/EGX) Pharma Industry Analysis
UpdatedApr 04, 2026
DataAggregated Company Financials
Companies11
- 7D1.8%
- 3M5.5%
- 1Y72.0%
- YTDn/a
In the last week, the Pharma industry is up 1.8%, with October PharmaE up 21%. Meanwhile, Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) actually underperformed within the industry, shrinking 5.3% in the last week. This means that the industry has gained 72% over the past year. Looking forward, earnings are forecast to grow by 25% annually.
Industry Valuation and Performance
Has the Egyptian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 04 Apr 2026 | ج.م54.3b | ج.م35.4b | ج.م3.8b | 17x | 14.1x | 1.5x |
| Mon, 02 Mar 2026 | ج.م52.6b | ج.م35.1b | ج.م3.9b | 12.7x | 13.5x | 1.5x |
| Wed, 28 Jan 2026 | ج.م49.3b | ج.م35.1b | ج.م3.9b | 13.6x | 12.5x | 1.4x |
| Fri, 26 Dec 2025 | ج.م50.7b | ج.م34.7b | ج.م3.8b | 16x | 13.3x | 1.5x |
| Sun, 23 Nov 2025 | ج.م48.7b | ج.م33.6b | ج.م3.6b | 16.1x | 13.4x | 1.5x |
| Tue, 21 Oct 2025 | ج.م51.1b | ج.م33.0b | ج.م3.7b | 15.1x | 13.8x | 1.6x |
| Thu, 18 Sep 2025 | ج.م41.4b | ج.م31.8b | ج.م3.6b | 13.8x | 11.6x | 1.3x |
| Sat, 16 Aug 2025 | ج.م36.5b | ج.م31.1b | ج.م3.4b | 10.8x | 10.9x | 1.2x |
| Mon, 14 Jul 2025 | ج.م31.5b | ج.م29.4b | ج.م3.1b | 8.8x | 10.3x | 1.1x |
| Wed, 11 Jun 2025 | ج.م29.9b | ج.م28.1b | ج.م2.8b | 6.9x | 10.8x | 1.1x |
| Fri, 09 May 2025 | ج.م29.4b | ج.م26.2b | ج.م2.8b | 8.1x | 10.5x | 1.1x |
| Sun, 06 Apr 2025 | ج.م28.4b | ج.م26.2b | ج.م2.8b | 7.9x | 10.1x | 1.1x |
| Tue, 04 Mar 2025 | ج.م26.6b | ج.م24.8b | ج.م2.7b | 6.9x | 9.9x | 1.1x |
| Thu, 30 Jan 2025 | ج.م25.1b | ج.م23.8b | ج.م2.4b | 9.1x | 10.5x | 1.1x |
| Sat, 28 Dec 2024 | ج.م23.0b | ج.م23.7b | ج.م2.4b | 8.6x | 9.7x | 1x |
| Mon, 25 Nov 2024 | ج.م23.1b | ج.م23.2b | ج.م2.3b | 6.8x | 9.8x | 1x |
| Wed, 23 Oct 2024 | ج.م24.8b | ج.م22.1b | ج.م2.1b | 7.2x | 11.5x | 1.1x |
| Fri, 20 Sep 2024 | ج.م20.8b | ج.م22.6b | ج.م2.2b | 5.9x | 9.3x | 0.9x |
| Sun, 18 Aug 2024 | ج.م18.5b | ج.م22.0b | ج.م2.4b | 5.2x | 7.7x | 0.8x |
| Tue, 16 Jul 2024 | ج.م18.8b | ج.م21.3b | ج.م2.5b | 5x | 7.7x | 0.9x |
| Thu, 13 Jun 2024 | ج.م18.0b | ج.م21.1b | ج.م2.4b | 5.9x | 7.5x | 0.9x |
| Sat, 11 May 2024 | ج.م18.2b | ج.م19.8b | ج.م1.9b | 7.8x | 9.8x | 0.9x |
| Mon, 08 Apr 2024 | ج.م21.0b | ج.م19.4b | ج.م2.3b | 7.9x | 9.3x | 1.1x |
| Wed, 06 Mar 2024 | ج.م23.5b | ج.م18.5b | ج.م2.4b | 9.7x | 9.8x | 1.3x |
| Fri, 02 Feb 2024 | ج.م20.2b | ج.م18.5b | ج.م2.4b | 8.1x | 8.5x | 1.1x |
| Sun, 31 Dec 2023 | ج.م18.2b | ج.م15.3b | ج.م2.1b | 6.5x | 8.8x | 1.2x |
| Tue, 28 Nov 2023 | ج.م19.2b | ج.م16.3b | ج.م2.2b | 9.5x | 8.9x | 1.2x |
| Thu, 26 Oct 2023 | ج.م15.1b | ج.م15.4b | ج.م1.9b | 6.2x | 7.8x | 1x |
| Sat, 23 Sep 2023 | ج.م14.4b | ج.م15.9b | ج.م2.0b | 7.1x | 7.1x | 0.9x |
| Mon, 21 Aug 2023 | ج.م13.7b | ج.م15.7b | ج.م2.1b | 7.6x | 6.5x | 0.9x |
| Wed, 19 Jul 2023 | ج.م13.6b | ج.م15.6b | ج.م2.1b | 7x | 6.4x | 0.9x |
| Fri, 16 Jun 2023 | ج.م13.9b | ج.م16.2b | ج.م2.2b | 5.4x | 6.3x | 0.9x |
| Sun, 14 May 2023 | ج.م13.3b | ج.م16.2b | ج.م2.4b | 4.1x | 5.5x | 0.8x |
| Tue, 11 Apr 2023 | ج.م14.7b | ج.م16.2b | ج.م2.4b | 5.2x | 6.1x | 0.9x |
Price to Earnings Ratio
6.1x
Current Industry PE
- Investors are optimistic on the Egyptian Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 14.1x which is higher than its 3-year average PE of 9.7x.
- The 3-year average PS ratio of 1.1x is lower than the industry's current PS ratio of 1.5x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 17% per year over the last three years.
- Revenues for these companies have grown 30% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Egyptian Pharma compare with similar industries?
| EG Market | 0.47% | |
| Healthcare | -0.43% | |
| Pharma | 1.75% | |
| Pharma | 1.75% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| OCPH October PharmaE | ج.م234.13 | 21.3% +ج.م493.7m | 127.7% | PE17x | |
| CPCI Kahira Pharmaceuticals & Chemical Industries | ج.م275.36 | 9.6% +ج.م361.4m | 96.4% | PE8.8x | |
| MIPH MINAPHARM Pharmaceuticals | ج.م475.41 | 3.3% +ج.م181.4m | 164.1% | PE50x | |
| ADCI Arab Drug | ج.م158.33 | 7.2% +ج.م127.9m | 94.4% | PE8.6x | |
| PHAR Egyptian International Pharmaceutical Industries | ج.م79.00 | 0.9% +ج.م116.4m | 56.5% | PE10.6x |